Checkpoint Therapeutics (CKPT) Insider Trading & Ownership $4.12 0.00 (0.00%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$4.12 0.00 (0.00%) As of 05/2/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Checkpoint Therapeutics (NASDAQ:CKPT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.10%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$2.34 M Get CKPT Insider Trade Alerts Want to know when executives and insiders are buying or selling Checkpoint Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CKPT Insider Buying and Selling by Quarter Checkpoint Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/2/2025James F Oliviero IIICEOSell15,090$4.04$60,963.60 4/1/2025William Garrett GrayCFOSell12,322$4.05$49,904.10 2/10/2025James F Oliviero IIICEOSell10,331$3.15$32,542.65 2/7/2025James F Oliviero IIICEOSell9,233$3.41$31,484.53 2/6/2025William Garrett GrayCFOSell74,110$3.67$271,983.70 12/19/2024James F Oliviero IIICEOSell220,230$3.38$744,377.40 12/18/2024William Garrett GrayCFOSell268,432$4.01$1,076,412.32 6/26/2024James F Oliviero IIICEOSell24,610$2.05$50,450.50 6/26/2024William Garrett GrayCFOSell13,038$2.06$26,858.28 (Data available from 1/1/2013 forward) CKPT Insider Trading Activity - Frequently Asked Questions Who is on Checkpoint Therapeutics's Insider Roster? The list of insiders at Checkpoint Therapeutics includes James F Oliviero III, and William Garrett Gray. Learn more on insiders at CKPT. What percentage of Checkpoint Therapeutics stock is owned by insiders? 2.10% of Checkpoint Therapeutics stock is owned by insiders. Learn more on CKPT's insider holdings. Which Checkpoint Therapeutics insiders have been selling company stock? The following insiders have sold CKPT shares in the last 24 months: James F Oliviero III ($955,879.32), and William Garrett Gray ($1,437,395.10). How much insider selling is happening at Checkpoint Therapeutics? Insiders have sold a total of 671,340 Checkpoint Therapeutics shares in the last 24 months for a total of $2,393,274.42 sold. Checkpoint Therapeutics Key ExecutivesMr. James F. Oliviero III (Age 48)C.F.A., President, CEO & Director Compensation: $921.59k4 recent tradesMr. William Garrett Gray (Age 37)CFO, Corporate Secretary & Treasurer Compensation: $409.12k3 recent trades More Insider Trading Tools from MarketBeat Related Companies Structure Therapeutics Insider Buying Ocular Therapeutix Insider Buying Dyne Therapeutics Insider Buying Ardelyx Insider Buying Iovance Biotherapeutics Insider Buying Amphastar Pharmaceuticals Insider Buying Syndax Pharmaceuticals Insider Buying Adaptive Biotechnologies Insider Buying Aurinia Pharmaceuticals Insider Buying 89bio Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles McDonald’s Insiders Sell Shares! Investors Should Do the Opposite5 Mid-Cap Stocks Insiders Are Buying This YearInsider Buying in This Stock Reiterates Analysts Bullish OutlookBeware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why This page (NASDAQ:CKPT) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredWhat President Trump’s Executive Order 14154 means for your moneyNearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Checkpoint Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Checkpoint Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CKPT Stock Free CKPT Stock Alerts